title: Association of C-reactive protein with surrogate measures of insulin resistance among nondiabetic US from National Health and Nutrition Examination Survey 1999-2002.
abstract: BACKGROUND
  Increased C-reactive protein (CRP) concentration and insulin resistance (IR) are associated with increased rates of adverse cardiovascular events. We sought to examine the relationship of CRP with surrogate measures of IR among nondiabetic adults in the US.
  
  
  METHODS
  We conducted analyses using data from the National Health and Nutrition Examination Survey 1999-2002. We analyzed a nationally representative sample of 2514 men and nonpregnant women age > or = 20 years who were non-Hispanic white, non-Hispanic black, or Mexican American.
  
  
  RESULTS
  After adjustment for age, sex, race/ethnicity, smoking status, systolic blood pressure, and serum concentrations of HDL cholesterol, LDL cholesterol, and triglyceride, CRP was significantly associated with 10 IR measures (all P values <0.01). The strength of the association attenuated after further adjustment for waist circumference (change in adjusted regression coefficients ranging from 60.0% to 75.1%). The association of CRP with each IR surrogate was similar (standardized regression coefficient ranges from 0.06 to 0.09). The association of CRP (>3 vs <1 mg/L) with the homeostasis model for assessment of IR (> or = 75th vs <75th percentile) was statistically significant among people with a body mass index > or = 30 kg/m(2) (odds ratio, 2.6; 95% CI, 1.3-5.1) or with a body mass index <25 kg/m(2) (odds ratio, 2.5; 95% CI, 1.5-4.2).
  
  
  CONCLUSIONS
  CRP was significantly associated with the surrogate measures of IR among nondiabetic adults. Obesity may play an important role in the association of CRP with IR in this nationally representative sample.
authors.affiliation: Department of Family Medicine, Morehouse School of Medicine, Atlanta, GA 30344, USA. ymeng@msn.edu
authors.forename: Yuan-Xiang
authors.initials: YX
authors.lastname: Meng
authors.forename: Earl S
authors.initials: ES
authors.lastname: Ford
authors.forename: Chaoyang
authors.initials: C
authors.lastname: Li
authors.forename: Alexander
authors.initials: A
authors.lastname: Quarshie
authors.forename: Ahmad M
authors.initials: AM
authors.lastname: Al-Mahmoud
authors.forename: Wayne
authors.initials: W
authors.lastname: Giles
authors.forename: Gary H
authors.initials: GH
authors.lastname: Gibbons
authors.forename: Gregory
authors.initials: G
authors.lastname: Strayhorn
mesh_terms: D000328:Adult; D044383:Black People; D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D002096:C-Peptide / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D005215:Fasting; D005260:Female; D006306:Health Surveys; D006706:Homeostasis; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D016015:Logistic Models; D008297:Male; D017058:Mexican Americans; D008875:Middle Aged; D009765:Obesity / Q000503:physiopathology; D012907:Smoking; D014280:Triglycerides / Q000097:blood; D014481:United States; D044465:White People; D001741:Black or African American
chemical_list: D001786:Blood Glucose; D002096:C-Peptide; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D007328:Insulin; D014280:Triglycerides; D002097:C-Reactive Protein